Ana B. Sanz

13.0k total citations · 5 hit papers
180 papers, 9.5k citations indexed

About

Ana B. Sanz is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Ana B. Sanz has authored 180 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Nephrology, 67 papers in Molecular Biology and 40 papers in Immunology. Recurrent topics in Ana B. Sanz's work include Chronic Kidney Disease and Diabetes (33 papers), Acute Kidney Injury Research (31 papers) and Cell death mechanisms and regulation (27 papers). Ana B. Sanz is often cited by papers focused on Chronic Kidney Disease and Diabetes (33 papers), Acute Kidney Injury Research (31 papers) and Cell death mechanisms and regulation (27 papers). Ana B. Sanz collaborates with scholars based in Spain, United States and Germany. Ana B. Sanz's co-authors include Alberto Ortíz, María Dolores Sánchez-Niño, Marta Ruiz‐Ortega, Jesús Egido, Adrián M. Ramos, Juan Antonio Moreno, Pilar Justo, Diego Martín‐Sánchez, Jonay Poveda and María C. Izquierdo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Ana B. Sanz

177 papers receiving 9.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury

2013 452 citations Andreas Linkermann, Ana B. Sanz et al. Proceedings of the National Academy of Sciences profile →
Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid–Induced AKI

2016 445 citations Diego Martín‐Sánchez, Olga Ruiz‐Andrés et al. Journal of the American Society of Nephrology profile →
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy

2020 232 citations Sandra Rayego‐Mateos, José Luis Morgado‐Pascual et al. International Journal of Molecular Sciences profile →
Regulated cell death pathways in kidney disease

2023 220 citations Ana B. Sanz, María Dolores Sánchez-Niño et al. profile →
The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases

2020 195 citations Miguel Fontecha‐Barriuso, Diego Martín‐Sánchez et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana B. Sanz Spain	55	3.9k	3.1k	1.6k	1.3k	1.1k	180	9.5k
María Dolores Sánchez-Niño Spain	53	3.0k 0.8×	2.9k 0.9×	1.3k 0.8×	1.0k 0.8×	974 0.9×	173	8.2k
Lin Sun China	50	4.3k 1.1×	2.8k 0.9×	862 0.5×	1.1k 0.9×	788 0.7×	207	9.6k
Xiangmei Chen China	52	3.3k 0.9×	3.7k 1.2×	1.2k 0.7×	623 0.5×	1.1k 0.9×	578	10.8k
Shougang Zhuang United States	53	4.8k 1.2×	2.4k 0.8×	828 0.5×	661 0.5×	1.1k 1.0×	213	9.0k
Yashpal S. Kanwar United States	59	6.3k 1.6×	3.7k 1.2×	1.6k 1.0×	1.1k 0.9×	1.0k 0.9×	234	13.8k
Hanna E. Abboud United States	57	3.7k 1.0×	2.3k 0.7×	1.6k 1.0×	682 0.5×	645 0.6×	166	9.0k
Reiko Inagi Japan	58	2.9k 0.8×	2.7k 0.9×	983 0.6×	1.0k 0.8×	553 0.5×	194	10.1k
Motoko Yanagita Japan	47	2.8k 0.7×	2.0k 0.7×	1.3k 0.8×	477 0.4×	971 0.8×	250	7.6k
Lili Zhou China	49	4.1k 1.1×	1.8k 0.6×	711 0.5×	859 0.7×	674 0.6×	295	8.8k
George F. Schreiner United States	56	4.2k 1.1×	3.1k 1.0×	1.5k 0.9×	647 0.5×	1.4k 1.2×	139	11.3k

Countries citing papers authored by Ana B. Sanz

Since Specialization

Citations

This map shows the geographic impact of Ana B. Sanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana B. Sanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana B. Sanz more than expected).

Fields of papers citing papers by Ana B. Sanz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana B. Sanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana B. Sanz. The network helps show where Ana B. Sanz may publish in the future.

Co-authorship network of co-authors of Ana B. Sanz

This figure shows the co-authorship network connecting the top 25 collaborators of Ana B. Sanz. A scholar is included among the top collaborators of Ana B. Sanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana B. Sanz. Ana B. Sanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luján, Manel, Javier Sayas Catalán, Daniel López‐Padilla, et al.. (2025). SEPAR Position Paper on the Use of High Flow Nasal Cannula Therapy in the Home Setting. Archivos de Bronconeumología. 62(1). 35–43.

Faguer, Stanislas, Ana B. Sanz, Justyna Siwy, et al.. (2024). Performances of acute kidney injury biomarkers vary according to sex. Clinical Kidney Journal. 17(5). sfae091–sfae091. 3 indexed citations

Rodríguez, Ramón María Alvargonzález, Elisenda Bañón-Maneus, María Laura Sáiz, et al.. (2024). Inhibition of BRD4 Attenuates ER Stress-induced Renal Ischemic-Reperfusion Injury. International Journal of Biological Sciences. 20(5). 1547–1562. 3 indexed citations

Castro-López, J., Ana B. Sanz, Vladimı́r Farkaš, et al.. (2024). Broad Protection against Invasive Fungal Disease from a Nanobody Targeting the Active Site of Fungal β‐1,3‐Glucanosyltransferases. Angewandte Chemie International Edition. 63(34). e202405823–e202405823. 3 indexed citations

Faguer, Stanislas, Nicholas M. Selby, Vincenzo Cantaluppi, et al.. (2024). Does amino acid infusion improve kidney outcomes in patients at high risk for postsurgical AKI?. Nephrology Dialysis Transplantation. 40(3). 412–414. 1 indexed citations

Sánchez-Niño, María Dolores, Sol Carriazo, Aránzazu Pintor‐Chocano, et al.. (2023). Interaction of Fabry Disease and Diabetes Mellitus: Suboptimal Recruitment of Kidney Protective Factors. International Journal of Molecular Sciences. 24(21). 15853–15853. 3 indexed citations

Rayego‐Mateos, Sandra, et al.. (2023). Regulated necrosis role in inflammation and repair in acute kidney injury. Frontiers in Immunology. 14. 1324996–1324996. 20 indexed citations

Poveda, Jonay, Laura González‐Lafuente, Elena Rodríguez‐Sánchez, et al.. (2023). Targeting the TWEAK–Fn14 pathway prevents dysfunction in cardiac calcium handling after acute kidney injury. The Journal of Pathology. 261(4). 427–441. 2 indexed citations

Fontecha‐Barriuso, Miguel, et al.. (2022). RIPK3 and kidney disease. SHILAP Revista de lepidopterología. 44(1). 10–22. 2 indexed citations

10.

Cuarental, Leticia, Aránzazu Pintor‐Chocano, Sol Carriazo, et al.. (2022). The transcription factor Fosl1 preserves Klotho expression and protects from acute kidney injury. Kidney International. 103(4). 686–701. 23 indexed citations

11.

Rayego‐Mateos, Sandra, Laura Márquez‐Expósito, Raquel Rodrigues‐Díez, et al.. (2022). Molecular Mechanisms of Kidney Injury and Repair. International Journal of Molecular Sciences. 23(3). 1542–1542. 57 indexed citations

12.

Martínez‐Moreno, Julio M., Miguel Fontecha‐Barriuso, Diego Martín‐Sánchez, et al.. (2020). The Contribution of Histone Crotonylation to Tissue Health and Disease: Focus on Kidney Health. Frontiers in Pharmacology. 11. 393–393. 30 indexed citations

13.

Martín‐Sánchez, Diego, Miguel Fontecha‐Barriuso, Susana Carrasco, et al.. (2018). TWEAK and RIPK1 mediate a second wave of cell death during AKI. Proceedings of the National Academy of Sciences. 115(16). 4182–4187. 118 indexed citations

14.

Castillo-Rodríguez, Esmeralda, Raúl Fernández-Prado, Raquel Esteras, et al.. (2018). Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression. Toxins. 10(7). 300–300. 109 indexed citations

15.

Martín‐Sánchez, Diego, Miguel Fontecha‐Barriuso, María Dolores Sánchez-Niño, et al.. (2018). Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields. Cell Death and Disease. 9(2). 118–118. 24 indexed citations

16.

Suárez-Álvarez, Beatriz, José Luis Morgado‐Pascual, Sandra Rayego‐Mateos, et al.. (2016). Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage. Journal of the American Society of Nephrology. 28(2). 504–519. 59 indexed citations

17.

Martín‐Sánchez, Diego, Olga Ruiz‐Andrés, Jonay Poveda, et al.. (2016). Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid–Induced AKI. Journal of the American Society of Nephrology. 28(1). 218–229. 445 indexed citations breakdown →

18.

Sánchez-Niño, María Dolores, Daniel Carpio, Ana B. Sanz, et al.. (2015). Lyso-Gb3 activates Notch1 in human podocytes. Human Molecular Genetics. 24(20). 5720–5732. 107 indexed citations

19.

Díez‐Domingo, Javier, et al.. (2006). ROTAVIRUS GASTROENTERITIS AMONG CHILDREN UNDER FIVE YEARS OF AGE IN VALENCIA, SPAIN. The Pediatric Infectious Disease Journal. 25(5). 455–457. 29 indexed citations

20.

Rivero, Fernando, et al.. (1998). Estudio de la toxicidad aguda y subcrónica de un extracto acuoso de Phyllanthus orbicularis. 15(2). 64–67. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact